Quick Answer
Insight Molecular Diagnostics Inc. reported Earnings Per Share Diluted of $1.65 (loss) per share for the year ending 2025.
- Insight Molecular Diagnostics Inc. showed an increase of +64.6% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Insight Molecular Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), Insight Molecular Diagnostics Inc.'s Earnings Per Share Diluted has grown by 87.5%.
- Historical annual values: Fiscal year 2025: $1.65 (loss) per share | Fiscal year 2024: $4.66 (loss) per share | Fiscal year 2023: $3.75 (loss) per share | Fiscal year 2022: $13.25 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: